{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:01:53Z","timestamp":1790996513692,"version":"4.1.0"},"reference-count":89,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12,20]]},"DOI":"10.4103\/0366-6999.247210","type":"journal-article","created":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T10:29:20Z","timestamp":1544437760000},"page":"2976-2985","source":"Crossref","is-referenced-by-count":38,"title":["Management Recommendations on Sleep Disturbance of Patients with Parkinson's Disease"],"prefix":"10.1097","volume":"131","author":[{"given":"Chun-Feng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Qin","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Qin","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Fang","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piu","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Bo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Di","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K Ray","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210129","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11940-017-0461-6","article-title":"Treatment of sleep dysfunction in Parkinson's disease","volume":"19","author":"Amara","year":"2017","journal-title":"Curr Treat Options Neurol"},{"key":"R2-12-20210129","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.sleep.2017.03.026","article-title":"Multifactorial sleep disturbance in Parkinson's disease","volume":"35","author":"Albers","year":"2017","journal-title":"Sleep Med"},{"key":"R3-12-20210129","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/bs.irn.2017.05.033","article-title":"Sleep dysfunction in Parkinson's disease","volume":"133","author":"Falup-Pecurariu","year":"2017","journal-title":"Int Rev Neurobiol"},{"key":"R4-12-20210129","first-page":"5567","article-title":"Clinical characteristics of sleep disorders in different subtypes of patients with Parkinson disease (in Chinese)","volume":"5","author":"Lou","year":"2011","journal-title":"Chin J Clin"},{"key":"R5-12-20210129","first-page":"3956","article-title":"Relevant factors of sleep disorders and their influences on the quality in patients with Parkinson disease (in Chinese)","volume":"6","author":"Yu","year":"2012","journal-title":"Chin J Clin"},{"key":"R6-12-20210129","first-page":"4309","article-title":"Correlation analysis of sleep disorder and cognitive dysfunction in patients with Parkinson disease (in Chinese)","volume":"9","author":"Ma","year":"2015","journal-title":"Chin J Clin"},{"key":"R7-12-20210129","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1620\/tjem.232.129","article-title":"Non-motor symptoms in treated and untreated Chinese patients with early Parkinson's disease","volume":"232","author":"Zhang","year":"2014","journal-title":"Tohoku J Exp Med"},{"key":"R8-12-20210129","first-page":"722","article-title":"Sleeping characteristics of PD patients and its influencing factors (in Chinese)","volume":"18","author":"Wang","year":"2016","journal-title":"Chin J Geriatr Heart Brain Vessel Dis"},{"key":"R10-12-20210129","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fneur.2017.00042","article-title":"The treatment of sleep disorders in Parkinson's disease: From research to clinical practice","volume":"8","author":"Loddo","year":"2017","journal-title":"Front Neurol"},{"key":"R11-12-20210129","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/mds.23829","article-title":"The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease","volume":"26","author":"Fox","year":"2011","journal-title":"Mov Disord"},{"key":"R12-12-20210129","first-page":"S1","article-title":"Management of Parkinson's disease: An evidence-based review","volume":"17","author":"Goetz","year":"2002","journal-title":"Mov Disord"},{"key":"R14-12-20210129","first-page":"29","article-title":"Clinical analysis of dyssomnia in Parkinson patients (in Chinese)","volume":"11","author":"He","year":"2008","journal-title":"Chin J Pract Nerv Dis"},{"key":"R15-12-20210129","first-page":"176","article-title":"Analysis of sleep disorders in Parkinson disease patients at early stage (in Chinese)","volume":"8","author":"Li","year":"2008","journal-title":"Chin J Contemp Neurol Neurosurg"},{"key":"R16-12-20210129","first-page":"2576","article-title":"Non-motor symptoms in patients with Parkinson's disease (in Chinese)","volume":"13","author":"Gao","year":"2010","journal-title":"Chin Gen Pract"},{"key":"R17-12-20210129","first-page":"3","article-title":"Analysis of occurrence rate of non-motor symptoms in 126 patients in Parkinson's disease (in Chinese)","volume":"16","author":"Ma","year":"2013","journal-title":"Chin J Pract Nerv Dis"},{"key":"R18-12-20210129","first-page":"623","article-title":"Analysis of characteristics of Parkinson's disease clinical sleep disorders (in Chinese)","volume":"16","author":"Tian","year":"2014","journal-title":"Chin J Med Guide"},{"key":"R19-12-20210129","first-page":"928","article-title":"A survey of sleep related cognitions in patients with Parkinson's disease and related nursing (in Chinese)","volume":"22","author":"Liang","year":"2015","journal-title":"Clin Med Eng"},{"key":"R20-12-20210129","first-page":"21","article-title":"Influence of sleep disorders on health-related quality of life in patients with Parkinson's disease (in Chinese)","volume":"24","author":"Zhang","year":"2017","journal-title":"Chin J Neuroimmunol Neurol"},{"key":"R22-12-20210129","first-page":"CD010459","article-title":"Music for insomnia in adults","volume":"8","author":"Jespersen","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R23-12-20210129","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1007\/PL00007731","article-title":"Sleep disorders in Parkinson's disease","volume":"245","author":"Stocchi","year":"1998","journal-title":"J Neurol"},{"key":"R24-12-20210129","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1468-1331.2010.03213.x","article-title":"Effect of controlled-release levodopa on the microstructure of sleep in Parkinson's disease","volume":"18","author":"Wailke","year":"2011","journal-title":"Eur J Neurol"},{"key":"R25-12-20210129","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1468-1331.2011.03442.x","article-title":"Improvements in nocturnal symptoms with ropinirole prolonged release in patients with advanced Parkinson's disease","volume":"19","author":"Ray Chaudhuri","year":"2012","journal-title":"Eur J Neurol"},{"key":"R26-12-20210129","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1212\/01.wnl.0000258660.74391.c1","article-title":"Ropinirole 24-hour prolonged release: Randomized, controlled study in advanced Parkinson disease","volume":"68","author":"Pahwa","year":"2007","journal-title":"Neurology"},{"key":"R27-12-20210129","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S1474-4422(07)70108-4","article-title":"Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: A double-blind, double-dummy, randomised controlled trial","volume":"6","author":"Poewe","year":"2007","journal-title":"Lancet Neurol"},{"key":"R28-12-20210129","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/mds.23441","article-title":"Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double-blind, randomized, placebo-controlled study (RECOVER)","volume":"26","author":"Trenkwalder","year":"2011","journal-title":"Mov Disord"},{"key":"R30-12-20210129","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.sleep.2016.01.016","article-title":"Rotigotine may improve sleep architecture in Parkinson's disease: A double-blind, randomized, placebo-controlled polysomnographic study","volume":"21","author":"Pierantozzi","year":"2016","journal-title":"Sleep Med"},{"key":"R32-12-20210129","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00702-010-0506-4","article-title":"Rotigotine transdermal system for control of early morning motor impairment and sleep disturbances in patients with Parkinson's disease","volume":"117","author":"Giladi","year":"2010","journal-title":"J Neural Transm (Vienna"},{"key":"R33-12-20210129","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.2147\/NDT.S116476","article-title":"Rasagiline for sleep disorders in patients with Parkinson's disease: A prospective observational study","volume":"12","author":"Schettino","year":"2016","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R34-12-20210129","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/ene.13567","article-title":"Rasagiline improves polysomnographic sleep parameters in patients with Parkinson's disease: A double-blind, baseline-controlled trial","volume":"25","author":"Schrempf","year":"2018","journal-title":"Eur J Neurol"},{"key":"R35-12-20210129","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1002\/mds.23168","article-title":"Treatment of insomnia in Parkinson's disease: A controlled trial of eszopiclone and placebo","volume":"25","author":"Menza","year":"2010","journal-title":"Mov Disord"},{"key":"R36-12-20210129","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.parkreldis.2013.03.003","article-title":"Doxepin and cognitive behavioural therapy for insomnia in patients with Parkinson's disease \u2013 A randomized study","volume":"19","author":"Rios Romenets","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"R37-12-20210129","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.sleep.2005.04.004","article-title":"Melatonin for sleep disturbances in Parkinson's disease","volume":"6","author":"Dowling","year":"2005","journal-title":"Sleep Med"},{"key":"R38-12-20210129","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00415-006-0390-x","article-title":"Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study","volume":"254","author":"Medeiros","year":"2007","journal-title":"J Neurol"},{"key":"R39-12-20210129","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/01.wnf.0000174932.82134.e2","article-title":"Quetiapine for insomnia in Parkinson disease: Results from an open-label trial","volume":"28","author":"Juri","year":"2005","journal-title":"Clin Neuropharmacol"},{"key":"R40-12-20210129","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1002\/mds.21741","article-title":"Rotigotine transdermal patch in early PARKINSON\u2019S disease: A randomized, double-blind, controlled study versus placebo and ropinirole","volume":"22","author":"Giladi","year":"2007","journal-title":"Mov Disord"},{"key":"R41-12-20210129","first-page":"831","article-title":"Clinical characteristics of sleep disorders in 96 patients in Parkinson's disease (in Chinese)","volume":"24","author":"He","year":"2005","journal-title":"Chin J Geriatr"},{"key":"R42-12-20210129","first-page":"5907","article-title":"Analysis of excessive daytime sleepiness of patients with Parkinson disease at early stage (in Chinese)","volume":"6","author":"Lou","year":"2012","journal-title":"Chin J Clin"},{"key":"R43-12-20210129","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.sleep.2013.12.021","article-title":"Clinical manifestations of Parkinson disease and the onset of rapid eye movement sleep behavior disorder","volume":"15","author":"Gong","year":"2014","journal-title":"Sleep Med"},{"key":"R44-12-20210129","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/jnnp-2016-315023","article-title":"Longitudinal assessment of excessive daytime sleepiness in early Parkinson's disease","volume":"88","author":"Amara","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R45-12-20210129","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.parkreldis.2016.01.020","article-title":"Course and risk factors for excessive daytime sleepiness in Parkinson's disease","volume":"24","author":"Zhu","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"R46-12-20210129","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/mds.10390","article-title":"Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson'sParkinson's disease","volume":"18","author":"Adler","year":"2003","journal-title":"Mov Disord"},{"key":"R47-12-20210129","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/sleep\/25.8.62","article-title":"Modafinil for the treatment of daytime sleepiness in Parkinson's disease: A double-blind, randomized, crossover, placebo-controlled polygraphic trial","volume":"25","author":"H\u00f6gl","year":"2002","journal-title":"Sleep"},{"key":"R48-12-20210129","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00002826-200203000-00010","article-title":"Treatment of excessive daytime sleepiness in patients with Parkinson's disease with modafinil","volume":"25","author":"Nieves","year":"2002","journal-title":"Clin Neuropharmacol"},{"key":"R49-12-20210129","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1136\/jnnp.2005.065870","article-title":"Modafinil for daytime somnolence in Parkinson's disease: Double blind, placebo controlled parallel trial","volume":"76","author":"Ondo","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R50-12-20210129","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.parkreldis.2016.03.002","article-title":"Pharmacological interventions for daytime sleepiness and sleep disorders in Parkinson's disease: Systematic review and meta-analysis","volume":"27","author":"Rodrigues","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"R51-12-20210129","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1002\/mds.23884","article-title":"The movement disorder society evidence-based medicine review update: Treatments for the non-motor symptoms of Parkinson's disease","volume":"26","author":"Seppi","year":"2011","journal-title":"Mov Disord"},{"key":"R52-12-20210129","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1212\/WNL.0b013e318263570d","article-title":"Caffeine for treatment of Parkinson disease: A randomized controlled trial","volume":"79","author":"Postuma","year":"2012","journal-title":"Neurology"},{"key":"R53-12-20210129","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1212\/WNL.0000000000004568","article-title":"Caffeine as symptomatic treatment for Parkinson disease (Caf\u00e9-PD): A randomized trial","volume":"89","author":"Postuma","year":"2017","journal-title":"Neurology"},{"key":"R54-12-20210129","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jns.2017.07.045","article-title":"Istradefylline improves daytime sleepiness in patients with Parkinson's disease: An open-label, 3-month study","volume":"380","author":"Suzuki","year":"2017","journal-title":"J Neurol Sci"},{"key":"R55-12-20210129","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/jnnp.2006.100016","article-title":"Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's disease","volume":"78","author":"Devos","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R56-12-20210129","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1212\/WNL.0b013e3181ebdd79","article-title":"Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease","volume":"75","author":"Weintraub","year":"2010","journal-title":"Neurology"},{"key":"R57-12-20210129","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/archneur.65.10.1337","article-title":"Sodium oxybate for excessive daytime sleepiness in Parkinson disease: An open-label polysomnographic study","volume":"65","author":"Ondo","year":"2008","journal-title":"Arch Neurol"},{"key":"R58-12-20210129","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.parkreldis.2012.01.008","article-title":"Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson's disease: A prospective, open-label extension study","volume":"18","author":"Elmer","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"R59-12-20210129","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00702-012-0925-5","article-title":"Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson's disease: Results of two open-label extension studies, CLEOPATRA-PD and PREFER","volume":"120","author":"LeWitt","year":"2013","journal-title":"J Neural Transm (Vienna"},{"key":"R60-12-20210129","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s007020170098","article-title":"A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy","volume":"108","author":"Pal","year":"2001","journal-title":"J Neural Transm (Vienna"},{"key":"R61-12-20210129","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S1474-4422(13)70225-4","article-title":"Pitolisant versus placebo or modafinil in patients with narcolepsy: A double-blind, randomised trial","volume":"12","author":"Dauvilliers","year":"2013","journal-title":"Lancet Neurol"},{"key":"R62-12-20210129","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12883-017-0795-4","article-title":"Meta-analysis on the prevalence of REM sleep behavior disorder symptoms in Parkinson's disease","volume":"17","author":"Zhang","year":"2017","journal-title":"BMC Neurol"},{"key":"R63-12-20210129","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10072-016-2744-1","article-title":"Prevalence of rapid eye movement sleep behavior disorder (RBD) in Parkinson's disease: A meta and meta-regression analysis","volume":"38","author":"Zhang","year":"2017","journal-title":"Neurol Sci"},{"key":"R64-12-20210129","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/jmri.25571","article-title":"Abnormal baseline brain activity in Parkinson's disease with and without REM sleep behavior disorder: A resting-state functional MRI study","volume":"46","author":"Li","year":"2017","journal-title":"J Magn Reson Imaging"},{"key":"R65-12-20210129","doi-asserted-by":"crossref","first-page":"230","DOI":"10.14336\/AD.2015.1026","article-title":"Effect of a leucine-rich repeat kinase 2 variant on motor and non-motor symptoms in Chinese Parkinson's disease patients","volume":"7","author":"Sun","year":"2016","journal-title":"Aging Dis"},{"key":"R66-12-20210129","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.parkreldis.2015.03.021","article-title":"Hyposmia correlates with SNCA variant and non-motor symptoms in Chinese patients with Parkinson's disease","volume":"21","author":"Chen","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"R67-12-20210129","doi-asserted-by":"crossref","first-page":"e0138997","DOI":"10.1371\/journal.pone.0138997","article-title":"Investigation on abnormal iron metabolism and related inflammation in Parkinson disease patients with probable RBD","volume":"10","author":"Hu","year":"2015","journal-title":"PLoS One"},{"key":"R68-12-20210129","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1212\/WNL.0000000000001308","article-title":"Parkinson disease with REM sleep behavior disorder: Features, \u03b1-synuclein, and inflammation","volume":"84","author":"Hu","year":"2015","journal-title":"Neurology"},{"key":"R69-12-20210129","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s11325-016-1366-4","article-title":"Retinal nerve fiber layer thinning: A window into rapid eye movement sleep behavior disorders in Parkinson's disease","volume":"20","author":"Yang","year":"2016","journal-title":"Sleep Breath"},{"key":"R70-12-20210129","doi-asserted-by":"crossref","first-page":"684","DOI":"10.4103\/0366-6999.201603","article-title":"Tonic electromyogram density in multiple system atrophy with predominant parkinsonism and Parkinson's disease","volume":"130","author":"Wang","year":"2017","journal-title":"Chin Med J"},{"key":"R71-12-20210129","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.clinph.2014.09.014","article-title":"Clinical correlates of rapid eye movement sleep without atonia in Parkinson's disease","volume":"126","author":"Shen","year":"2015","journal-title":"Clin Neurophysiol"},{"key":"R72-12-20210129","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S1474-4422(06)70476-8","article-title":"Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: A descriptive study","volume":"5","author":"Iranzo","year":"2006","journal-title":"Lancet Neurol"},{"key":"R73-12-20210129","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1474-4422(13)70056-5","article-title":"Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: An observational cohort study","volume":"12","author":"Iranzo","year":"2013","journal-title":"Lancet Neurol"},{"key":"R74-12-20210129","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S1474-4422(06)70441-0","article-title":"Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases","volume":"5","author":"Gagnon","year":"2006","journal-title":"Lancet Neurol"},{"key":"R75-12-20210129","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/mds.27018","article-title":"REM sleep behavior disorder in Parkinson's disease and other synucleinopathies","volume":"32","author":"St Louis","year":"2017","journal-title":"Mov Disord"},{"key":"R76-12-20210129","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.sleep.2012.10.015","article-title":"Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder","volume":"14","author":"Boeve","year":"2013","journal-title":"Sleep Med"},{"key":"R77-12-20210129","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1080\/01616412.2016.1204495","article-title":"Effect of low-intensity pure tone auditory stimulation on patients with rapid eye movement sleep behavior disorder","volume":"38","author":"Zhang","year":"2016","journal-title":"Neurol Res"},{"key":"R78-12-20210129","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.5664\/jcsm.6200","article-title":"Effects of rotigotine on REM sleep behavior disorder in Parkinson disease","volume":"12","author":"Wang","year":"2016","journal-title":"J Clin Sleep Med"},{"key":"R79-12-20210129","first-page":"1418","article-title":"Lack of effects of pramipexole on REM sleep behavior disorder in Parkinson disease","volume":"31","author":"Kumru","year":"2008","journal-title":"Sleep"},{"key":"R80-12-20210129","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.parkreldis.2012.08.010","article-title":"Factors associated with the effect of pramipexole on symptoms of idiopathic REM sleep behavior disorder","volume":"19","author":"Sasai","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"R81-12-20210129","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.psychres.2016.06.055","article-title":"Pramipexole in the treatment of REM sleep behaviour disorder: A critical review","volume":"243","author":"Tan","year":"2016","journal-title":"Psychiatry Res"},{"key":"R82-12-20210129","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/mds.26929","article-title":"Restless legs syndrome and periodic leg movements in patients with movement disorders: Specific considerations","volume":"32","author":"H\u00f6gl","year":"2017","journal-title":"Mov Disord"},{"key":"R83-12-20210129","doi-asserted-by":"crossref","first-page":"405","DOI":"10.5665\/sleep.5452","article-title":"Afour-year longitudinal study on restless legs syndrome in Parkinson disease","volume":"39","author":"Moccia","year":"2016","journal-title":"Sleep"},{"key":"R84-12-20210129","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/ane.12307","article-title":"Restless legs syndrome in patients with Parkinson's disease: A comparative study on prevalence, clinical characteristics, quality of life and nutritional status","volume":"131","author":"Fereshtehnejad","year":"2015","journal-title":"Acta Neurol Scand"},{"key":"R85-12-20210129","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12883-015-0267-7","article-title":"Rotigotine transdermal system as add-on to oral dopamine agonist in advanced Parkinson's disease: An open-label study","volume":"15","author":"Kim","year":"2015","journal-title":"BMC Neurol"},{"key":"R87-12-20210129","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11325-016-1414-0","article-title":"An observational clinical and video-polysomnographic study of the effects of rotigotine in sleep disorder in Parkinson's disease","volume":"21","author":"Wang","year":"2017","journal-title":"Sleep Breath"},{"key":"R88-12-20210129","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1111\/ene.13449","article-title":"Gabapentin enacarbil, pregabalin and rotigotine are equally effective in restless legs syndrome: A comparative meta-analysis","volume":"24","author":"Iftikhar","year":"2017","journal-title":"Eur J Neurol"},{"key":"R89-12-20210129","first-page":"CD006939","article-title":"Benzodiazepines for restless legs syndrome","volume":"3","author":"Carlos","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R91-12-20210129","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1212\/WNL.0000000000003738","article-title":"Reduced cognitive function in patients with Parkinson disease and obstructive sleep apnea","volume":"88","author":"Mery","year":"2017","journal-title":"Neurology"},{"key":"R92-12-20210129","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.sleep.2016.01.001","article-title":"Obstructive sleep apnea and cognition in Parkinson's disease","volume":"21","author":"Harmell","year":"2016","journal-title":"Sleep Med"},{"key":"R93-12-20210129","doi-asserted-by":"crossref","first-page":"e100828","DOI":"10.1371\/journal.pone.0100828","article-title":"Observations on sleep-disordered breathing in idiopathic Parkinson's disease","volume":"9","author":"Valko","year":"2014","journal-title":"PLoS One"},{"key":"R94-12-20210129","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.sleep.2014.09.014","article-title":"Supine sleep and obstructive sleep apnea syndrome in Parkinson's disease","volume":"16","author":"Cochen De Cock","year":"2015","journal-title":"Sleep Med"},{"key":"R95-12-20210129","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1164\/rccm.201212-2223OC","article-title":"Health outcomes of continuous positive airway pressure versus oral appliance treatment for obstructive sleep apnea: A randomized controlled trial","volume":"187","author":"Phillips","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"R96-12-20210129","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11325-015-1208-9","article-title":"Obstructive sleep apnea in Parkinson's disease patients: Effect of Sinemet CR taken at bedtime","volume":"20","author":"Gros","year":"2016","journal-title":"Sleep Breath"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/0366-6999.247210","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T19:50:04Z","timestamp":1623959404000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00029330-201812200-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,20]]},"references-count":89,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.4103\/0366-6999.247210","relation":{},"ISSN":["0366-6999"],"issn-type":[{"value":"0366-6999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12,20]]}}}